Functional solubilization of aggregation-prone HIV envelope proteins by covalent fusion with chaperone modules

Journal of Molecular Biology

Volumn 345, Issue 5, 2005, Pages 1229-1241

  Scholz, Christian ^a   Schaarschmidt, Peter ^a   Engel, Alfred Michael ^a   Andres, Herbert ^a   Schmitt, Urban ^a   Faatz, Elke ^a   Balbach, Jochen ^b   Schmid, Franz Xaver ^b  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

^b UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

FkpA; PPIase chaperones; protein folding; retroviral ectodomain; SlyD

Indexed keywords

CHAPERONE; CYCLOPHILIN; CYSTEINE FREE SENSITIVE TO LYSIS D PROTEIN; ENVELOPE PROTEIN; FKP 506 BINDING PROTEIN A; GLYCOPROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 21; GLYCOPROTEIN GP 36; GLYCOPROTEIN GP 41; HYBRID PROTEIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RETROVIRUS; SOLUBILIZATION;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 11844279155     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.10.091     Document Type: Article

References (58)

1. D.M. Eckert, and P.S. Kim Mechanisms of viral membrane fusion and its inhibition Annu. Rev. Biochem. 70 2001 777 810
2. M. Moulard, and E. Decroly Maturation of HIV envelope glycoprotein precursors by cellular endoproteases Biochim. Biophys. Acta Rev. Biomembr. 1469 2000 121 132
3. D.C. Chan, D. Fass, J.M. Berger, and P.S. Kim Core structure of gp41 from the HIV envelope glycoprotein Cell 89 1997 263 273
4. W. Weissenhorn, A. Dessen, S.C. Harrison, J.J. Skehel, and D.C. Wiley Atomic structure of the ectodomain from HIV-1 gp41 Nature 387 1997 426 430
5. M. Lu, S.C. Blacklow, and P.S. Kim A trimeric structural domain of the HIV-1 transmembrane glycoprotein Nature Struct. Biol. 2 1995 1075 1082
6. M.J. Root, M.S. Kay, and P.S. Kim Protein design of an HIV-1 entry inhibitor Science 291 2001 884 888
7. R.W. Doms, and J.P. Moore HIV-1 membrane fusion: targets of opportunity J. Cell Biol. 151 2000 F9 F13
8. C.H. Chen, T.J. Matthews, C.B. Mcdanal, D.P. Bolognesi, and M.L. Greenberg A molecular clasp in the human-immunodeficiency-virus (HIV) type-1 Tm protein determines the anti-HIV activity of Gp41 derivatives-implication for viral fusion J. Virol. 69 1995 3771 3777
9. D.C. Chan, C.T. Chutkowski, and P.S. Kim Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target Proc. Natl Acad. Sci. USA 95 1998 15613 15617
10. D.M. Eckert, and P.S. Kim Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region Proc. Natl Acad. Sci. USA 98 2001 11187 11192
11. J.W. Gnann, J.B. Mccormick, S. Mitchell, J.A. Nelson, and M.B.A. Oldstone Synthetic peptide immunoassay distinguishes HIV type-1 and HIV type-2 infections Science 237 1987 1346 1349
12. J.W. Gnann, P.L. Schwimmbeck, J.A. Nelson, A.B. Truax, and M.B.A. Oldstone Diagnosis of aids by using a 12-amino acid peptide representing an immunodominant epitope of the human-immunodeficiency-virus J. Infect. Dis. 156 1987 261 267
13. H. Döbeli, H. Andres, N. Breyer, N. Draeger, D. Sizmann, M.T. Zuber, B. Weinert, and B. Wipf Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage Protein Expr. Purif. 12 1998 404 414
14. M. Lu, and P.S. Kim A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein J. Biomol. Struct. Dynam. 15 1997 465 471
15. V.N. Malashkevich, D.C. Chan, C.T. Chutkowski, and P.S. Kim Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides Proc. Natl Acad. Sci. USA 95 1998 9134 9139
16. M. Caffrey, M.L. Cai, J. Kaufman, S.J. Stahl, P.T. Wingfield, and D.G. Covell Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41 EMBO J. 17 1998 4572 4584
17. M. Caffrey, J. Kaufman, S. Stahl, P. Wingfield, A.M. Gronenborn, and G.M. Clore Monomer-trimer equilibrium of the ectodomain of SIV gp41: insight into the mechanism of peptide inhibition of HIV infection Protein Sci. 8 1999 1904 1907
18. J.J.G. Wang, S. Steel, R. Wisniewolski, and C.Y. Wang Detection of antibodies to human T-lymphotropic virus type-III by using a synthetic peptide of 21 amino-acid-residues corresponding to a highly antigenic segment of Gp41 envelope protein Proc. Natl Acad. Sci. USA 83 1986 6159 6163
19. B. Kobe, R.J. Center, B.E. Kemp, and P. Poumbourios Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins Proc. Natl Acad. Sci. USA 96 1999 4319 4324
20. F.X. Schmid, L.M. Mayr, M. Mucke, and E.R. Schönbrunner Prolyl isomerases-role in protein-folding Advan. Protein Chem. 44 1993 25 66
21. F.X. Schmid Prolyl isomerases Protein Fold. Cell 59 2002 243 282
22. S. Behrens, R. Maier, H. de Cock, F.X. Schmid, and C.A. Gross The SurA periplasmic PPIase lacking its parvulin domains functions in vivo and has chaperone activity EMBO J. 20 2001 285 294
23. C. Scholz, G. Stoller, T. Zarnt, G. Fischer, and F.X. Schmid Cooperation of enzymatic and chaperone functions of trigger factor in the catalysis of protein folding EMBO J. 16 1997 54 58
24. T. Zarnt, T. Tradler, G. Stoller, C. Scholz, F.X. Schmid, and G. Fischer Modular structure of the trigger factor required for high activity in protein folding J. Mol. Biol. 271 1997 827 837
25. C. Wülfing, J. Lombardero, and A. Plückthun An Escherichia coli protein consisting of a domain homologous to Fk506-binding proteins (Fkbp) and a new metal-binding motif J. Biol. Chem. 269 1994 2895 2901
26. T.G. Bernhardt, W.D. Roof, and R. Young Genetic evidence that the bacteriophage phi X174 lysis protein inhibits cell wall synthesis Proc. Natl Acad. Sci. USA 97 2000 4297 4302
27. W.D. Roof, and R. Young Phi-X174 lysis requires Slyd, a host gene which is related to the Fkbp family of peptidyl-prolyl cis-trans isomerases FEMS Microbiol. Rev. 17 1995 213 218
28. M. Caffrey, M.L. Cai, J. Kaufman, S.J. Stahl, P.T. Wingfield, A.M. Gronenborn, and G.M. Clore Determination of the secondary structure and global topology of the 44 kDa ectodomain of gp41 of the simian immunodeficiency virus by multidimensional nuclear magnetic resonance spectroscopy J. Mol. Biol. 271 1997 819 826
29. P.T. Wingfield, S.J. Stahl, J. Kaufman, A. Zlotnick, C.C. Hyde, A.M. Gronenborn, and G.M. Clore The extracellular domain of immunodeficiency virus gp41 protein: expression in Escherichia coli, purification, and crystallization Protein Sci. 6 1997 1653 1660
30. J.M. Scholtz, and R.L. Baldwin The mechanism of alpha-helix formation by peptides Annu. Rev. Biophys. Biomol. Struct. 21 1992 95 118
31. W.D. Kohn, C.M. Kay, and R.S. Hodges Protein destabilization by electrostatic repulsions in the 2-stranded alpha-helical coiled-coil leucine-zipper Protein Sci. 4 1995 237 250
32. W.D. Kohn, O.D. Monera, C.M. Kay, and R.S. Hodges The effects of interhelical electrostatic repulsions between glutamic-acid residues in controlling the dimerization and stability of 2-stranded alpha-helical coiled-coils J. Biol. Chem. 270 1995 25495 25506
33. M.B.A. Oldstone, A. Tishon, H. Lewicki, H.J. Dyson, V.A. Feher, N. Assamunt, and P.E. Wright Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus-Gp41 transmembrane protein-peptide conformation analysis using monoclonal-antibodies and proton nuclear-magnetic-resonance spectroscopy J. Virol. 65 1991 1727 1734
34. J.W. Gnann, J.A. Nelson, and M.B.A. Oldstone Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human- immunodeficiency-virus J. Virol. 61 1987 2639 2641
35. M. Caffrey Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop Biochim. Biophys. Acta Mol. Basis Dis. 1536 2001 116 122
36. R.J. Center, B. Kobe, K.A. Wilson, T. Teh, G.J. Howlett, B.E. Kemp, and P. Poumbourios Crystallization of a trimeric human T cell leukemia virus type 1 gp21 ectodomain fragment as a chimera with maltose-binding protein Protein Sci. 7 1998 1612 1619
37. S. Marqusee, V.H. Robbins, and R.L. Baldwin Unusually stable helix formation in short alanine-based peptides Proc. Natl Acad. Sci. USA 86 1989 5286 5290
38. C.A. Rohl, W. Fiori, and R.L. Baldwin Alanine is helix-stabilizing in both template-nucleated and standard peptide helices Proc. Natl Acad. Sci. USA 96 1999 3682 3687
39. K. Ramm, and A. Plückthun The periplasmic Escherichia coli peptidylprolyl cis,trans-isomerase FkpA-II. Isomerase-independent chaperone activity in vitro J. Biol. Chem. 275 2000 17106 17113
40. K. Ramm, and A. Plückthun High enzymatic activity and chaperone function are mechanistically related features of the dimeric E. coli peptidyl-prolyl-isomerase FkpA J. Mol. Biol. 310 2001 485 498
41. H. Bothmann, and A. Plückthun The periplasmic Escherichia coli peptidylprolyl cis,trans-isomerase FkpA-I. Increased functional expression of antibody fragments with and without cis-prolines J. Biol. Chem. 275 2000 17100 17105
42. J.P. Arie, N. Sassoon, and J.M. Betton Chaperone function of FkpA, a heat shock prolyl isomerase, in the periplasm of Escherichia coli Mol. Microbiol. 39 2001 199 210
43. F.A. Saul, J.P. Arie, B.V.L. Normand, R. Kahn, J.M. Betton, and G.A. Bentley Structural and functional studies of FkpA from Escherichia coli, a cis/trans peptidyl-prolyl isomerase with chaperone activity J. Mol. Biol. 335 2004 595 608
44. T. Muster, F. Steindl, M. Purtscher, A. Trkola, A. Klima, and G. Himmler A conserved neutralizing epitope on Gp41 of human-immunodeficiency-virus type-1 J. Virol. 67 1993 6642 6647
45. M.B. Zwick, A.F. Labrijn, M. Wang, C. Spenlehauer, E.O. Saphire, and J.M. Binley Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41 J. Virol. 75 2001 10892 10905
46. U. Fiebig, O. Stephan, R. Kurth, and J. Denner Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology 307 2003 406 413
47. M. Caffrey, D.T. Braddock, J.M. Louis, M.A. Abu-Asab, D. Kingma, and L. Liotta Biophysical characterization of gp41 aggregates suggests a model for the molecular mechanism of HIV-associated neurological damage and dementia J. Biol. Chem. 275 2000 19877 19882
48. G. Stempfer, B. HöllNeugebauer, and R. Rudolph Improved refolding of an immobilized fusion protein Nature Biotechnol. 14 1996 329 334
49. G. Stempfer, B. HöllNeugebauer, E. Kopetzki, and R. Rudolph A fusion protein designed for noncovalent immobilization: stability, enzymatic activity, and use in an enzyme reactor Nature Biotechnol. 14 1996 481 484
50. E.D. Clark, E. Schwarz, and R. Rudolph Inhibition of aggregation side reactions during in vitro protein folding Amyloid, Prions Other Protein Aggregates 309 1999 217 236
51. W. Weissenhorn, S.A. Wharton, L.J. Calder, P.L. Earl, B. Moss, and E. Aliprandis The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide EMBO J. 15 1996 1507 1514
52. R. Maier, C. Scholz, and F.X. Schmid Dynamic association of trigger factor with protein substrates J. Mol. Biol. 314 2001 1181 1190
53. H. Bach, Y. Mazor, S. Shaky, A. Shoham-Lev, Y. Berdichevsky, D.L. Gutnick, and I. Benhar Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies J. Mol. Biol. 312 2001 79 93
54. R.B. Kapust, and D.S. Waugh Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused Protein Sci. 8 1999 1668 1674
55. D.S. Waugh, R.B. Kapust, and J.D. Fox E-coli maltose binding protein is uncommonly effective at inhibiting the aggregation of proteins to which it is fused Abstr. Pap. Am. Chem. Soc. 217 1999 U181 U181
56. L. Ratner, W. Haseltine, R. Patarca, K.J. Livak, B. Starcich, and S.F. Josephs Complete nucleotide-sequence of the Aids virus, HTLV-III Nature 313 1985 277 284
57. F. Clavel, M. Guyader, D. Guetard, M. Salle, L. Montagnier, and M. Alizon Molecular-cloning and polymorphism of the human immune-deficiency virus type-2 Nature 324 1986 691 695
58. S.C. Gill, and P.H. von Hippel Calculation of protein extinction coefficients from amino acid sequence data Anal. Biochem. 182 1989 319 326